Onconova

ONTX NASDAQ
2.240
-0.040
-1.75%
Closed 16:00 08/22 EDT
Open
2.270
Prev Close
2.280
High
2.290
Low
2.210
Volume
9.46K
Avg Vol (3M)
29.15K
52 Week High
11.17
52 Week Low
1.690
% Turnover
0.16%
Market Cap
13.44M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Onconova ONTX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.
MORE >

Recently

Name
Price
%Change